Delcath Systems Inc (DCTH)

[SAMNOTSAMUEL]

The short answer is this company loses money at close to $25 million per year, clinical trials have been sadly lengthy, or another way to view $200 million is the likely price tag to get from failure in 2013 to success maybe 2021 or 2022, and then still could be bankruptcy during the next decade. That's the stock market, get over it